Atlas Capital Advisors LLC Invests $33,000 in Zoetis Inc (NYSE:ZTS)

Atlas Capital Advisors LLC bought a new position in shares of Zoetis Inc (NYSE:ZTS) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 261 shares of the company’s stock, valued at approximately $33,000.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in Zoetis by 1.0% in the second quarter. Vanguard Group Inc. now owns 36,765,577 shares of the company’s stock worth $4,172,526,000 after buying an additional 346,167 shares during the period. Polen Capital Management LLC lifted its holdings in Zoetis by 0.9% in the second quarter. Polen Capital Management LLC now owns 10,188,554 shares of the company’s stock worth $1,156,299,000 after buying an additional 86,364 shares during the period. Nuveen Asset Management LLC lifted its holdings in Zoetis by 40,874.9% in the second quarter. Nuveen Asset Management LLC now owns 7,078,826 shares of the company’s stock worth $803,376,000 after buying an additional 7,061,550 shares during the period. Northern Trust Corp lifted its holdings in Zoetis by 1.0% in the second quarter. Northern Trust Corp now owns 5,963,894 shares of the company’s stock worth $676,842,000 after buying an additional 58,435 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Zoetis by 9.5% in the second quarter. Bank of New York Mellon Corp now owns 4,420,261 shares of the company’s stock worth $501,654,000 after buying an additional 383,799 shares during the period. Institutional investors own 89.95% of the company’s stock.

Several analysts have commented on the stock. Credit Suisse Group set a $138.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a report on Friday, October 11th. Argus set a $140.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a report on Wednesday, September 4th. ValuEngine lowered shares of Zoetis from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Goldman Sachs Group assumed coverage on shares of Zoetis in a report on Monday, September 9th. They issued a “conviction-buy” rating and a $145.00 price objective for the company. Finally, Stifel Nicolaus set a $140.00 price objective on shares of Zoetis and gave the stock a “buy” rating in a report on Friday, September 13th. Eight equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. Zoetis presently has a consensus rating of “Buy” and a consensus target price of $125.20.

Shares of NYSE ZTS opened at $117.86 on Friday. Zoetis Inc has a fifty-two week low of $78.90 and a fifty-two week high of $130.20. The company has a 50 day simple moving average of $125.46 and a two-hundred day simple moving average of $116.48. The company has a market capitalization of $57.43 billion, a price-to-earnings ratio of 37.65, a P/E/G ratio of 2.98 and a beta of 0.88. The company has a debt-to-equity ratio of 2.74, a quick ratio of 2.87 and a current ratio of 4.17.

Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, November 7th. The company reported $0.94 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.88 by $0.06. Zoetis had a net margin of 22.74% and a return on equity of 72.86%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the firm earned $0.83 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. On average, analysts forecast that Zoetis Inc will post 3.57 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Tuesday, October 22nd will be paid a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend is Monday, October 21st. Zoetis’s dividend payout ratio is 21.09%.

In related news, EVP Clinton A. Jr. Lewis sold 6,123 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of $120.05, for a total transaction of $735,066.15. Following the completion of the sale, the executive vice president now owns 41,698 shares of the company’s stock, valued at $5,005,844.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Kristin C. Peck sold 11,500 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $123.22, for a total transaction of $1,417,030.00. Following the sale, the executive vice president now directly owns 48,877 shares of the company’s stock, valued at approximately $6,022,623.94. The disclosure for this sale can be found here. Insiders have sold 34,332 shares of company stock valued at $4,258,182 in the last ninety days. Insiders own 0.29% of the company’s stock.

Zoetis Company Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Featured Story: Capital gains and your 401(k) or IRA

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.